These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17319096)

  • 21. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of statins in vascular disease.
    Laws PE; Spark JI; Cowled PA; Fitridge RA
    Eur J Vasc Endovasc Surg; 2004 Jan; 27(1):6-16. PubMed ID: 14652831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review.
    Balk EM; Lau J; Goudas LC; Jordan HS; Kupelnick B; Kim LU; Karas RH
    Ann Intern Med; 2003 Oct; 139(8):670-82. PubMed ID: 14568856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of statins: new therapeutic targets in drug design.
    Bedi O; Dhawan V; Sharma PL; Kumar P
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleiotropic effects of statins: moving beyond cholesterol control.
    Garcia PJ
    Curr Atheroscler Rep; 2005 Feb; 7(1):34-9. PubMed ID: 15683600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of statins, beyond lipid-lowering properties.
    Mihos CG; Pineda AM; Santana O
    Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy in cardiovascular diseases other than atherosclerosis.
    Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
    Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative statin therapy for patients undergoing cardiac surgery.
    Kuhn EW; Slottosch I; Wahlers T; Liakopoulos OJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008493. PubMed ID: 26270008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin therapy for vascular failure.
    Inoue T; Node K
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):281-95. PubMed ID: 17682928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
    Miida T; Hirayama S; Nakamura Y
    J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.
    Waters DD
    J Cardiol; 2010 Mar; 55(2):155-62. PubMed ID: 20206067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pleiotropic Effects of Statins in Endocrine Disorders.
    De La Cruz JA; Mihos CG; Horvath SA; Santana O
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):787-793. PubMed ID: 30924424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.